Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsy

OBJECTIVE: Evaluate the impact of concomitant enzyme (CYP3A4)-inducer antiepileptic drugs (EIAEDs) on the efficacy and safety of perampanel in patients from the 3 phase-III clinical trials. METHODS: Patients with pharmacoresistant partial-onset seizures in the 3 phase-III clinical studies were aged...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Gidal, Barry E., Laurenza, Antonio, Hussein, Ziad, Yang, Haichen, Fain, Randi, Edelstein, Jacob, Kumar, Dinesh, Ferry, Jim
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4433458/
https://ncbi.nlm.nih.gov/pubmed/25878177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000001558
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados